COLLABORATION AGREEMENTS - Covid 19 Collaboration (Details) - Covid 19 Collaboration |
1 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2021
CAD ($)
|
Feb. 28, 2021
CAD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Jan. 31, 2021 |
|
COLLABORATION AGREEMENTS | |||||||
Amount contributed recorded in research and development expenses | $ 10,306 | ||||||
Expense funded | $ 25,000 | $ 77,549 | |||||
Pro-rata share of losses of investment | $ 2,353 | ||||||
Aggregated redemption price | $ 2,353 | ||||||
Payout received upon termination | $ 128,000 | ||||||
BCNI | |||||||
COLLABORATION AGREEMENTS | |||||||
Equity method, ownership percentage | 50.00% | 50.00% | |||||
Payments to acquire equity method investment | $ 2,353 |
X | ||||||||||
- Definition The amount of aggregated redemption price upon termination. No definition available.
|
X | ||||||||||
- Definition Represents the amount contributed recorded in research and development expenses. No definition available.
|
X | ||||||||||
- Definition The amount of expense funded in equity method. No definition available.
|
X | ||||||||||
- Definition The payout received upon termination of equity method. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|